ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF

ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF Share · CA74836M1068 (ARCX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF
No Price
30.04.2026 20:00
Current Prices from ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
QPTFF
USD
30.04.2026 20:00
0,03 USD
0,00 USD
Asset Allocation
AssetPercentage %
Stock US50,87 %
Bond39,09 %
Other3,44 %
Stock non-US3,26 %
Cash3,24 %
NotClassified0,10 %
Largest Positions
SymbolISINNamePercentage %
VANGUARD LONG-T.. 23,96 %
INVESCO QQQ TRU.. 21,90 %
TECHNOLOGY SELE.. 17,03 %
ISHARES 20+ YEA.. 16,86 %
INVESCO NASDAQ .. 9,32 %
ISHARES 1-3 YEA.. 4,32 %
ISHARES RUSSELL.. 4,11 %
FIDELITY INSTL .. 3,06 %
CASH 3,06 %
Region Distribution
RegionPercentage %
North America94,97 %
Asia Emerging3,07 %
Latin America0,81 %
Asia Developed0,68 %
Europe Developed0,21 %
Europe Emerging0,13 %
Africa/Middle East0,13 %
Australasia0,00 %
Japan0,00 %
United Kingdom0,00 %
Sector Distribution
SectorPercentage %
Technologie57,30 %
Telekommunikation15,78 %
Verbrauchsgüter12,26 %
Finanzdienstleistungen6,13 %
Gesundheitswesen3,34 %
Industrieunternehmen2,29 %
Basiskonsumgüter2,25 %
Versorgungsunternehmen0,42 %
Immobilien0,22 %
Grundstoffe0,00 %
Company Profile for ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF Share
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; skin penetrating active molecules for cosmetic and pharmaceutical use; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Fund Master Data
Issuer AdvisorShares
Asset Class ETF
Name AdvisorShares Q Portfolio Blended Allocation ETF
Fund Currency USD
Category Allocation--50% to 70% Equity
Fund Key Figures
Fund Size 3.478,58 EUR
Investment Strategy
The investment seeks to maximize total return over the long-term. The fund invests in ETFs representing all asset classes, including, but not limited to, treasury bonds, municipal bonds, investment grade corporate bonds, high-yield U.S. corporate bonds (sometimes referred to as junk bonds), municipal bonds, U.S. and foreign equities, and commodities. These underlying investments may be of any market capitalization, duration, maturity, and quality.

Company Data

Name ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF
Company Quest PharmaTech Inc.
Website https://www.questpharmatech.com
Primary Exchange ARCX NYSE
ISIN CA74836M1068
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ragupathy Madiyalakan
Country Canada
Currency USD
Employees -
Address 8123 Roper Road NW, T6E 6S4 Edmonton
IPO Date 2018-08-24

Ticker Symbols

Name Symbol
Over The Counter QPTFF
More Shares
Investors who hold ADVISORSHARES Q PORTFOLIO BLENDED ALLOCATION ETF also have the following shares in their portfolio:
Funai Soken Holdings Incorporated
Funai Soken Holdings Incorporated Share
H.B. FULLER 2027
H.B. FULLER 2027 Bond